How many courses of treatment do I need for Oplusituzumab/Ointouzumab (Besponsa)?

A course of treatment with oxinuximab/oxinuximab (Besponsa) is usually a continuous course, the duration and frequency of which will vary based on the patient's specific condition and the severity of the condition. The goal of treatment is to achieve durable leukemia remission or cure, so multiple courses may be needed.

1. Initial treatment course:Oxantuzumab/Oxantuzumab is usually administered continuously in one cycle, which is usually 28 days. The goals of initial treatment are to reduce the number of leukemia cells, relieve symptoms, and control the progression of leukemia.

2. Continuing treatment: After an initial course of treatment, patients often require multiple consecutive courses of treatment. These courses of treatment may last several months or even longer, depending on the patient's condition and response to treatment. The goals of ongoing treatment are to maintain leukemia in remission and prevent recurrence.

3. Treatment monitoring: During treatment, doctors will regularly monitor the patient's blood parameters, including white blood cell count, anemia degree, platelet count, etc. This helps assess the effectiveness of treatment and adjust medication dosage as needed.

4. Treatment response: Patient's treatment response will vary based on individual differences. Some patients may experience faster leukemia remission after an initial course of treatment, while others may take longer to see significant results. Doctors will develop a personalized treatment plan based on each patient's situation.

5. Cure and remission:Oxetuzumab/OxantuzumabThe ultimate goal is to achieve durable remission or cure of leukemia. This may require multiple courses of treatment, and patients usually receive regular follow-up and monitoring after treatment ends to make sure the leukemia does not come back again.

Ogaintozumab/Ointozumab has been launched in China, but it is not included in medical insurance. The domestic price is around 60,000 to 70,000 yuan, which is very expensive. Patients can buy it domestically. There are only original drugs available abroad, mainly Pfizer’s original drugs, which cost more than 80,000 yuan.